Home
Market Capitalization of Prism Medico & Pharmacy Ltd

Prism Medico & Pharmacy Ltd
NSE: PRISMMEDICO
Market Cap
Key Highlights
- The Market Cap of Prism Medico & Pharmacy Ltd is ₹ 9.61 crore as of 21 Feb 25 .
- The Latest Trading Price of Prism Medico & Pharmacy Ltd is ₹ 15.85 as of 21 Feb 15:30 .

Prism Medico & Pharmacy Ltd
NSE: PRISMMEDICO
Share Price
Market Price of Prism Medico & Pharmacy Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 15.85 |
20 Feb 2025 | 15.31 |
19 Feb 2025 | 14.63 |
18 Feb 2025 | 14.79 |
17 Feb 2025 | 15.56 |
14 Feb 2025 | 15.85 |
13 Feb 2025 | 16.68 |
12 Feb 2025 | 15.92 |
11 Feb 2025 | 16.05 |
10 Feb 2025 | 16.7 |
SWOT Analysis Of Prism Medico & Pharmacy Ltd
BlinkX Score for Prism Medico & Pharmacy Ltd
Asset Value vs Market Value of Prism Medico & Pharmacy Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Prism Medico & Pharmacy Ltd
Historical P/E Ratio of Prism Medico & Pharmacy Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Prism Medico & Pharmacy Ltd
Historical Revenue of Prism Medico & Pharmacy Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Prism Medico & Pharmacy Ltd
Historical EBITDA of Prism Medico & Pharmacy Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Prism Medico & Pharmacy Ltd
Historical Net Profit of Prism Medico & Pharmacy Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Prism Medico & Pharmacy Ltd
Dividend Payout Over Time
About Prism Medico & Pharmacy Ltd
- Prism Medico and Pharmacy Limited was originally incorporated in the name of Woolite Mercantile Company Limited on 21st February, 1985.
- The Company name was then changed from Woolite Mercantile Company Limited to Prism Medico and Pharmacy Limited on January 9, 2012.
- Initially, the Company was engaged into Wholesale and Retail of straw, fodder and other animal/poultry feed.
- It also engaged into investments, share trading, and financial activities. Recently, the Company was not able to carry out any major operations, resulting it engaged in trading.
- During FY 2022-23, the main objects of the Memorandum of Association of the Company were altered so as to 'manufacture, formulate, process, develop, refine, import, export, wholesale and/or retail trade all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods.
Prism Medico & Pharmacy Ltd News Hub
Prism Medico & Pharmacy reports standalone net loss of Rs 0.09 crore in the June 2024 quarter
Net Loss of Prism Medico & Pharmacy reported to Rs 0.09 crore in the quarter ended June 2024 as agai
Read more
14 Aug 24
Prism Medico and Pharmacy to hold board meeting
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 14 August
Read more
12 Aug 24
Prism Medico and Pharmacy to conduct board meeting
Prism Medico and Pharmacy will hold a meeting of the Board of Directors of the Company on 5 Septembe
Read more
03 Sept 24
Prism Medico and Pharmacy AGM scheduled
Prism Medico and Pharmacy announced that the Annual General Meeting (AGM) of the company will be hel
Read more
18 Sept 24